| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PHOENIX BIOTECH ACQUISITION CORP. | Director | Common Stock | 50,000 | $5,000 | $0.1000 | 14 Feb 2024 | Direct |
| CERO THERAPEUTICS HOLDINGS, INC. | Director | Stock Option (Right to Buy) | 112,500 | 25 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 25 Mar 2024 | 1 | $0 | 4 | Director | 27 Mar 2024, 21:28 |
| CERO | PHOENIX BIOTECH ACQUISITION CORP. | 14 Feb 2024 | 0 | $0 | 3 | Director | 16 Feb 2024, 19:29 |